| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Revenues | 7,368,220 | 14,711,421 | ||
| Cost of revenues | 5,948,565 | 11,062,007 | ||
| Gross profit | 1,419,655 | 3,649,414 | ||
| Selling and marketing | 1,625,511 | 1,694,837 | ||
| General and administrative | 749,573 | 654,567 | ||
| Research and development | 329,505 | 329,096 | ||
| Total operating expenses | 2,704,589 | 2,678,500 | ||
| Operating income | -1,284,934 | 970,914 | ||
| Interest income, net | 54 | 27,176 | ||
| Other loss, net | 987 | -57,442 | ||
| Income before income taxes | -1,283,893 | 940,648 | ||
| Income tax credit/(expense) | -463,970 | 319,425 | ||
| Net income attributable to the companys shareholders | -819,923 | 621,223 | ||
| Basic earnings per share | -0.04 | 0.03 | ||
| Diluted earnings per share | -0.04 | 0.03 | ||
| Weighted average shares used in calculating net income per share - basic | 20,000,000 | 20,000,000 | ||
| Weighted average shares used in calculating net income per share - diluted | 20,000,000 | 20,000,000 | ||
Papa Medical Inc. (PAPA)
Papa Medical Inc. (PAPA)